| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V76093 | (25S)-Antcin B | 1312711-71-9 | Antcin-B is a potent inhibitor of 3CLPro with high affinity. |
|
V121821 | (H)S(OMe)-DFR-kbt | (H)S(OMe)-DFR-kbt is a potent and selective TMPRSS2 inhibitor with a Ki value of 0.13 nM. | |
|
V35118 | (Rac)-X77 | 2144491-78-9 | (Rac)-X77 is the racemate of X77. |
|
V53358 | Antiviral agent 5 | 2698336-82-0 | antiviral compound 5 is an intermediate for antiviral active molecules targeting 3C and 3CL proteases like: SARS-CoV-2 Mpro. |
|
V29256 | AT-9010 triethylamine | 2648089-95-4 | AT-9010 triethylamine is the triphosphate bioactive metabolite of AT-527 and is a potent inhibitor of NiRAN (a function essential for viral replication). |
|
V129734 | Azelastine-d3 | 758637-88-6 | Azelastine-d3 is a deuterium-labeled azelastine. |
|
V129921 | BBH-4 | BBH-4 is a major protease (MPro) inhibitor of SARS-CoV-2. | |
|
V41681 | Bemnifosbuvir hemisulfate (RG-6422; AT-527) | 2241337-84-6 | Bemnifosbuvir hemisulfate (RG-6422; AT-527), the hemisulfate salt of AT-511, is a guanosine nucleotide prodrug and orally bioactive HCV viral replication inhibitor. |
|
V111960 | BFC220 | 143-85-1 | BFC220 is a covalent SARS-CoV-2 Mpro inhibitor with an IC50 of 2.77 μM. |
|
V105339 | C-467929 | 351891-58-2 | C-467929 is a Nsp15 endoribonuclease inhibitor with IC50 of 8 μM. |
|
V134007 | DMA-155 | 2237925-69-6 | DMA-155 is an antiviral agent that binds to the 5' stem-circular RNA of SARS-CoV-2 with affinities of 51.1 μM (SL1), 61.1 μM (SL4), 54.5 μM (SL5a), 66.9 μM (SL5b), and 48.6 μM (SL6). |
|
V39191 | EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) | 3258-02-4 | EIDD-1931(EIDD1931; Beta-d-N4-hydroxycytidine; NHC) is anovel and potentribonucleoside analog with antiviral activity. |
|
V91726 | Enuzovimab | 2531098-91-4 | Enuzovimab is a humanized IgG4 κ monoclonal antibody against SARS-CoV-2. |
|
V52043 | GRL-1720 | 2835511-03-8 | GRL-1720 is a potent SARS-CoV-2 Mpro inhibitor (antagonist) with EC50 of 15 µM. |
|
V80220 | Imiquimod-d6 (R 837-d6) | Imiquimod-d6 is the deuterium labelled form of Imiquimod. | |
|
V138333 | K22 | 2141978-86-9 | K22 is an anti-coronavirus compound. |
|
V141373 | Nirmatrelvir-d6 | 2861202-75-5 | Nirmatrelvir-d6 is a deuterium-labeled nirmatrelvir. |
|
V106194 | NQK-A8 peptide | The NQK-A8 peptide is an immunodominant peptide of the seasonal coronaviruses HKU1-CoV and OC43-CoV. | |
|
V106311 | P315V3 | P315V3 is a pan-coronavirus inhibitor that inhibits SARS-CoV-2 prototype PT, Delta, BA.1, and BA.4 strains with IC50 of 10.9, 8.9, 8.6, and 2.7 nM, respectively. | |
|
V41524 | PF-00835231 (PF-835231) | 870153-29-0 | PF-00835231 (PF-835231) is a potent 3CLpro [main protease (Mpro)] inhibitor developed by Pfizer for COVID-19treatment. |